Ozempic Could Be Much less Efficient for Emotional Eaters, Research Suggests

GLP-1 agonists—so-called “wonder medication” like Ozempic or Wegovy that assist people decrease blood sugar ranges and shed extra pounds, amongst different issues—yield important outcomes for some sufferers, however not all. Individuals’s motivations to overeat might play a job on this, in keeping with a brand new research.

To research why some folks don’t profit from GLP-1 agonists as a lot as others, researchers noticed 92 members with sort 2 diabetes in Japan throughout their first 12 months of taking GLP-1 medication. Their results, revealed in the present day in Frontiers in Medical Diabetes and Healthcare, counsel that individuals who overeat attributable to exterior causes—such because the sight or odor of scrumptious meals—had better probabilities of responding effectively to the medication in the long run than individuals who overeat for emotional causes.

Who will profit most from GLP-1 medication?

“Pre-treatment evaluation of consuming habits patterns might assist predict who will profit most from GLP-1 receptor agonist remedy,” Daisuke Yabe, senior creator of the research and a professor of diabetes, endocrinology, and diet at Kyoto College, mentioned in a Frontiers assertion. “GLP-1 receptor agonists are efficient for people who expertise weight acquire or elevated blood glucose ranges attributable to overeating triggered by exterior stimuli. Nonetheless, their effectiveness is much less anticipated in instances the place emotional consuming is the first trigger.”

The staff revealed this by gathering information on the members’ physique weight and composition, eating regimen, and knowledge akin to blood glucose, levels of cholesterol, and relationship with meals in the beginning of the therapy, three months after, and one 12 months after. They targeted on emotional consuming (consuming in response to damaging feelings), exterior consuming (consuming as a result of the meals appears to be like good), and restrained consuming (controlling one’s eating regimen to shed extra pounds). Whereas it might sound contradictory, extreme restrained consuming can truly end in disordered consuming, in keeping with the researchers.

Over the 12 months, the members skilled a statistically important lack of physique weight and lowered levels of cholesterol and physique fats share with out altering skeletal muscle mass. Whereas blood glucose ranges ameliorated, the development wasn’t statistically important. There have been, nonetheless, some variations relying on consuming behaviors. Three months after the beginning of the therapy, members reported extra restrained consuming and fewer exterior or emotional consuming. By the top of the 12 months, although, members had returned to their authentic restrained and emotional consuming habits.

“One potential rationalization is that emotional consuming is extra strongly influenced by psychological components which might not be straight addressed by GLP-1 receptor agonist remedy,” mentioned Takehiro Kato, second creator of the article and a researcher from Gifu College, “People with distinguished emotional consuming tendencies might require extra behavioral or psychological help.”

Exterior consuming lessened over the 12 months of therapy

Members reported decreased exterior consuming all through your entire 12 months, and people that claimed excessive ranges of exterior consuming in the beginning of the therapy noticed the best advantages in blood glucose ranges and weight reduction. Alternatively, the staff didn’t determine any affiliation between emotional or restrained consuming scores in the beginning and drug advantages by the 12-month mark.

“Whereas our research suggests a possible affiliation between exterior consuming habits and therapy response to GLP-1 receptor agonists, these findings stay preliminary,” defined Yabe. What’s extra, the staff’s research was observational, and members self-reported info, which means the researchers revealed a possible affiliation, not a causation.

“Additional proof is critical earlier than they are often carried out in scientific observe. Ought to future large-scale or randomized managed trials validate this relationship, incorporating easy behavioral assessments might grow to be a helpful part in optimizing therapy methods,” Yabe concluded.